William Larue Insider Profile
4 Followers
William Larue, former Director at TRACON Pharmaceuticals, holds 7.76K shares in TRACON Pharmaceuticals (Ticker: TCON), holds 26.17K shares in Oncternal Therapeutics (Ticker: ONCT), holds ― shares in Histogen (Ticker: HSTOQ). Most recently, William Larue Sold ― shares of TRACON Pharmaceuticals on Jan 19, 2023 for an estimated value of $150.00.
William Larue's Trading History
| TCONTRACON Pharmaceuticals | Jan 19, 2023 | ― | Informative Sell | 150.00 | $248.42 | |
| ONCTOncternal Therapeutics | Jun 11, 2019 | ― | Uninformative Buy | ― | $13.77K | |
| CADXCadence Pharma | Mar 21, 2014 | ― | Uninformative Sell | 224.00K | ― | |
| HSTOQHistogen | ― | ― | ― | ― |
You May Also Like
William Larue insider profile FAQ
What is the percentage of profitable transactions made by William Larue?
The percentage of profitable transactions made by William Larue is 50%.
What is the average return per transaction made by William Larue?
The average return per transaction made by William Larue is 20.00%.
What stocks does William Larue hold?
William Larue holds: TCON, ONCT, HSTOQ, CADX stocks.
What was William Larue’s latest transaction?
William Larue’s latest transaction was an Informative Sell of $150.00.
What was William Larue's most profitable transaction?
William Larue’s most profitable transaction was an Informative Sell of TCON stock on January 19, 2023. The return on the trade was 91.00%.
What is William Larue's role in TRACON Pharmaceuticals?
William Larue's role in TRACON Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
